Outpatient antifungal use survey.docVIP

 PAGE \* MERGEFORMAT 8 Outpatient antifungal use survey Abstract The extraction outpatient dermatology and obstetrics and gynecology in 1997, prescribing the same period in 1998 to investigate the use of antifungal agents; The results showed that: antifungal drug usage increased 14.42 percent from 1997 to 1998 and 16.06%, of which the older generation imidazole drugs (miconazole, etc.) to reduce consumption, a new generation triazole drugs (such as fluconazole) showed increasing trend. Drug use by clinical needs, formulation and other factors. Keywords: antifungal; Dermatology; Obstetrics and Gynecology In recent years, due to broad-spectrum antibiotics, corticosteroids, immunosuppressive agents, as well as extensive use of large-scale operation carried out, deep fungal infections increased the incidence of the increasingly 〔 1〕 . The rational use of antifungal agents are also increasingly subject to attention. In order to evaluate the use of antifungal agents are reasonable, this paper, a large general hospital in Obstetrics and Gynecology Dermatology and the use of antifungal agents to investigate the situation. 1 Materials and methods Randomly selected out-patient dermatology, obstetrics and gynecology in May 1997 for 10-day full prescribing 3507, while taking two subjects on the same day in 1998 with all the prescription 3860. Detection of antifungal drugs from prescription number, then the division, staging a variety of antifungal agents to calculate the ratio. 2 Results ① dermatology prescription 5143, in which antifungal prescription 840 (16.33%); Obstetrics and Gynecology prescription 2224, antifungal prescription 286 (12.85%). Dermatology usage is high (see Table 1). ② two subjects using basic antifungal agents on the rise, shown in Table 2. Dermatology Obstetrics and Gynecology Fluconazole Capsules 140 52 Miconazole Cream 395 13 Sporanox capsules 91 51 Bifonazole 146 2 Ketoconazole Tablets 18 2 Mico